0
Views
7
CrossRef citations to date
0
Altmetric
The prostate

The Role of Growth Factors in the Human Prostate

&
Pages 53-58 | Published online: 30 Mar 2023

REFERENCES

  • Bascom CC, Sipes NJ, Coffey RJ, Moses HL. Regulation of epithelial cell proliferation by transforming growth factors. J Cell Biochem 1989; 39: 25–33.
  • Bennet JP, Yamamura HI. Uro-transmitter, hormone, or drug receptor binding methods. Neuro transmitter receptor binding, 2nd edit. Raven Press, 1985; 61–89.
  • Carpenter G, King L, Cohen S. Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature 1978; 276: 409–410.
  • Carpenter G, Cohen S. In: Biochemical actions of hormones (Ed. G. Litwack), Academic Press, New York. 1978; 5: 203–247.
  • Cohen S, Carpenter G. Human epidermal growth factor: isolation of chemical and biological properties. Proc Nat Acad Sci USA 1975; 72: 1317–1321.
  • Cohen S, Ushiro H, Stoscheck C, Chinkers M. A native 170000 epidermal growth factor receptor kinase complex from plasma membrane vesicle. J Biol Chem 1982; 257: 1523–1531.
  • Cunha GR, Chung LWK, Shannon JM, Reese BA. Stromal/epithelial interaction in sex differentiation. Biol Reprod 1980; 22: 19–42.
  • Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A. Schlessinger J, Waterfield MD. Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature 1984; 307: 521–527.
  • Eaton CL, Davies P, Philips MEA. Growth factor involvement in oncogene expression of prostate tumours. J Ster Biochem 1988; 30: 341–345.
  • Elson SD, de Braun CA, Thorburn JD. Identification of epidermal growth factor-like activity in human male reproductive tissues and fluids. J Clin Endoc Metab 1984; 58: 589–594.
  • Fitzpatrick SL, LaChance MP, Schultz JS. Characterisation of epidermal growth factor receptor in action on human breast cancer cells in culture. Cancer Res 1984; 44: 3442–3447.
  • Gray A, Dull TJ, Ullrich A. Nuclite type sequence of epidermal growth factor cDNA predicts a 28000 m.w. protein precursor. Nature 1983; 303: 722–725.
  • Gregory H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Ann Rev Biochem 1975; 48: 193–216.
  • Gregory H, Wiltshire IR, Kavanagh JP, Blacklock NJ, Chowdury S, Richards RC. Urogastrone — epidermal growth factor concentration in prostatic fluid of normal individuals and patients with benign prostatic hypertrophy. Clin Sci 1986; 70: 359–363.
  • Gullick WJ, Marsden JJ, Whittle N, Ward B, Bobrow L, Waterfield MD. Expression of epidermal growth factor receptors on human cervical ovarian and vulval carcinomas. Cancer Res 1986; 46: 285–292.
  • Habib FK, Maddy SQ. Are epidermal growth factor receptors present in the human prostate. In: Protides of the Biological Fluids, (ed. Peelers, H) Pergamon Press, 1987; 315–318.
  • Habib FK. Peptide growth factors: A new frontier in prostate cancer. In: Prostate Cancer and Testicular Cancer. EORTC Genito-Urinary Group Monograph 7. (ed. Newling D.W.W.) Alan D Liss. Inc: New York. 1990; 107–115.
  • Hendler FJ, Ozanne B. Humans, cell lung cancer expressed increase epidermal growth factor receptors. J Clin Invest 1984; 74: 647–65.
  • Hill DJ. Growth factors and their cellular action. J Reprod Fertil 1989; 85: 723–734.
  • Hiraki V, Inoue H, Kato Y, Fukuya M, Susuki F. Combined effects of somatomedin-li growth factors with fibroblast growth factor epidermal growth factor in DNA synthesis in rabbit controsites. Mol Cell Biochem 1987; 76: 185.
  • Hirata Y, Orth DN. Epidermal growth factor (urogastrone) in human fluids: size, heterogeneity. J Clin Endoc Metab 1979; 48: 673–679.
  • Jacobs SC, Lawson RK. Mitogenic factors in human prostate extracts. Urol 1980; 16: 488–493.
  • James R, Bradshaw RA. Polypeptide growth factors. Ann Rev Biochem 1984; 53: 259–292.
  • Jinno H, Ueda K, Otazuro K, Kato T, Ito J. Prostate growth factor in extracts of benign prostatic hypertrophy. Eur Urol 1986; 12: 41–48.
  • King LH Jr, Carpenter G, Cohen S. Characterisation by electrophoresis of epidermal growth factor stimulated phosphorylation using A431 membranes. Biochem 1980; 19: 1524–1528.
  • Macdonald A, Chisholm GD, Habib FK. Production and response of a human prostatic cancer line to transforming growth factor-like molecules. Br J Cancer 1990; 62: 579–583.
  • Macdonald A, Habib FK. Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Int J Cancer 1991 (submitted for publication).
  • Maddy SQ, Chisholm GD, Hawkins RA, Habit FK. Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods. J Endocr 1987; 113: 147–153.
  • Maddy SQ, Chisholm GD, Busuttil A, Habib FK. Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour. Br J Cancer 1989; 60: 41–44.
  • Maehama S, Li D, Nanri H, Leykm JF, Deuel TF. Purification partial characterisation of the state derived growth factor. Proc Nat Acad Sci USA 1986; 83: 8162–8166.
  • Massague J. Epidermal growth factor—like transforming growth factor. J Biol Chem 1983; 258: 13614–13620.
  • Nishi N, Matuo Y, Magurama Y, Yoshitake Y, Nishikawa K, Wada F. Human prostatic growth factor (hPGF): partial purification and characterisation. Biochem Biophys Comm 1985; 132: 1103–1109.
  • Nonomura N, Nakamura N, Uchida N, Nogushi S, Sato B, Sonoda T, Matsumoto K. Growth-stimulatory effect of androgen induced autocrione growth factor(s) secreted from Shionogi carcinoma 115 cells on androgen unresponsive cancer cells in a paracrine mechanism. Cancer Res 1988; 48: 4904–1908.
  • Riedel S, Schlessinger J, Ullrich A. Chimeric, ligand binding verbB/EGF receptor retains transforming activity. Science 1987; 236: 197–200.
  • Sainsbury JRC, Sherbet GV, Farndon JR, Harris AL. Epidermal growht factor receptor in oestrogen receptor human breast cancer. Lancet 1985; 1: 660.
  • Schlessinger J. Allosteric regulation of the epidermal growth factor receptor kinase. J Cell Biol 1986; 103: 2067–2073.
  • Schuurmans ALG, Bold JN, Mulder E. Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumour cell line LNCaP. Prostate 1988; 12: 55–63.
  • Sporn MB, Roberts AB. Autocrine growth factors and cancer. Nature 1985; 313: 745–747.
  • Story MT, Jacobs SC, Lawson RK. Epidermal growth factor is not the major growth promoting agent in extracts of prostatic tissue. J Urol 1983; 130: 175–179.
  • Traish AM, Wotiz HH. Prostatic epidermal growth factor receptors and their regulation by androgens. Endocrinol 1987; 121: 1461–1467.
  • Waterfield MD. Structure — function and relationships of growth factors and their receptors. Br Med Bull 1989; 45: 541–544.
  • Wilding G, Valverius E, Knabbt C, Gelmann AP. The role of transforming growth factor — a in human prostate cancer cell growth. Prostate 1989; 15: 1–12.
  • Winkler ME, O'Connor L, Winget M, Fendly B. Epidermal growth factor and transforming growth factor — a bind differently to the epidermal growth factor receptor. Biochem 1989; 28: 6373–6378.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.